People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Flagship Biosciences, Inc. | — | Biotechnology | Series B | $26.8M | $39.3M | 2018 |
Holger Dean Lange at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Holger Dean Lange on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William Snider | 1 | 7 |
| Trevor Johnson | 1 | 2 |
| Tom Turi | 1 | 1 |
| Herb Hooper | 1 | 1 |
| Bill H. Snider | 1 | 1 |
| Fisher Aaron | 1 | 1 |
| Herb H. Hooper | 1 | 1 |
| Tom H. Turi | 1 | 1 |
| Joe Dean Kruger | 1 | 1 |
| Nancy Dean Gillett | 1 | 1 |
| G. David Young | 1 | 1 |
| Gary Dean Clark | 1 | 1 |
| L. Dean Northey | 1 | 1 |
| Dean David Northey | 1 | 1 |
| Nancy A. Gillett | 1 | 1 |
| Gary M. Clark | 1 | 1 |
| Gregory K. Tucker | 1 | 1 |
| Paul Kirchgraber | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.